Full Professor, Institut de recherches cliniques de Montréal

Dr. André Veillette is Full Research Professor at the IRCM and Université de Montréal. Throughout his career, he has worked in the field of immunology where he helped found the field of immune cell activation 30 years ago. Since then, he has made important discoveries regarding CD4 and CD8 T cell co-receptors and surface antigens, the protein tyrosine kinases Csk and Lck, the role of the adaptor molecule SAP in immune regulation and the role of innate immune cells in immuno-oncology. These and other discoveries have provided fundamental insights into the immunological mechanisms of health and ...

Leader mondial incontestable des "Proprotéines Convertases", ayant cloné sept des neuf Convertases, Nabil G. Seidah démontre leurs implications dans plusieurs pathologies humaines, notamment le rôle de PCSK9 dans l'hypercholestérolémie familiale. Il est à l'origine du médicament le plus efficace à ce jour pour réduire le LDL-cholestérol sanguin. Il est auteur de plus de 760 publications et a prononcé 470 conférences dans 30 pays. Ses découvertes majeures font partie des manuels de biochimie et de médecine. Passionné par la découverte, il a formé une relève de 150 étudiants/chercheurs. Son ...

Professor Emeritus, University of Alberta

Cyril Kay is one of Canada’s leading protein biochemists. He was the founding co- Director of Canada’s first MRC Group – The Protein Structure and Function Group at the University of Alberta. Dr. Kay is the author of over 340 peer-reviewed articles. His research focused on the structure and function of muscle and calcium binding proteins. For this work, he has won many distinctions including The Ayerst Award of the Canadian Biochemical Society (1970), Fellowship in the Royal Society (1978), the Order of Canada (1995), and the ASTech Lifetime Achievement Award in 2006. Four years after his ...

Professor Emerita, Queen's University

Professor Susan P.C. Cole (PhD, FRSC) is internationally renowned for her ground-breaking and paradigm-shifting pioneering studies related to the discovery and characterization of the human ATP binding cassette transporter, MRP1, a membrane protein which mediates the extrusion of drugs and other organic molecules from normal and malignant cells. Her work on the biochemical mechanisms of drug resistance over the past 25 years has had a major impact not only in our understanding of how cancer cells can survive in the presence of cytotoxic agents, but also of how such agents are distributed ...

Full Professor, Université de Sherbrooke

Les activités de recherche du professeur Chabot ont permis de développer une expertise canadienne dans le domaine de l`ARN. Son leadership en recherche fondamentale et la qualité de ses travaux ont été intimement associés à un souci de développement technologique. Les travaux de recherche du professeur Chabot contribuent de façon importante à la compréhension des mécanismes contrôlant la diversité protéomique et la fonction des gènes tout en encourageant le développement de thérapies originales, notamment dans la lutte contre le cancer.